A study on dulaglutide for brain artery narrowing after stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if a once-weekly injection called dulaglutide (Trulicity) helps people with severe narrowing of a major brain artery after a minor stroke or TIA. The goal is to improve blood flow and reduce the risk of another stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 80 years old.
- You have had a minor stroke or TIA in the past 3 months with severe narrowing of a major brain artery (the internal carotid or middle cerebral).
- You can walk without help from another person (modified Rankin score of 0 to 3).
- You do not have advanced kidney disease or need dialysis.
- You do not have atrial fibrillation, a history of pancreatitis, or certain types of thyroid cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares using a genetic test to choose between two anti-clot medications (clopidogrel and ticagrelor) versus the usual approach of giving clopidogrel alone. It aims to see if personalized treatment can better prevent strokes in people with narrowed brain arteries.
This trial studies whether an intracranial stent (a small mesh tube placed inside the brain artery) improves outcomes and safety for people with severe, symptomatic narrowing of brain arteries. It may help if symptoms continue despite antiplatelet medicine or if blood flow to the brain is poor.
This trial tests whether a medication commonly used for diabetes can help patients who had a stroke due to a blocked large artery in the brain. The drug is given as an injection after the standard procedure to remove the blood clot, and researchers will see if it leads to better recovery.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
This trial tests whether semaglutide changes blood flow in the brain and the brain’s “barrier” (how well the brain is protected) in people with type 2 diabetes. It may help researchers understand brain-related effects of diabetes treatment using scans and blood tests.
This trial tests whether a medicine called a GLP-1 receptor agonist (similar to diabetes drugs) can improve recovery after a specific type of bleeding stroke. The study aims to see if this drug can reduce brain swelling and help patients regain function.
Hear when a new Intracranial Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.